Antiplatelet, anticoagulant or both? A tool for pharmacists.
作者信息
Schmode Alyssa, Ackman Margaret, Bungard Tammy J
机构信息
Alberta Health Services Pharmacy Services (Schmode, Ackman), University of Alberta, Edmonton, Alberta.
Division of Cardiology (Bungard), University of Alberta, Edmonton, Alberta.
出版信息
Can Pharm J (Ott). 2019 Aug 13;152(5):291-300. doi: 10.1177/1715163519866232. eCollection 2019 Sep-Oct.
Abstract
摘要
相似文献
1
Antiplatelet, anticoagulant or both? A tool for pharmacists.抗血小板药、抗凝药还是两者并用？药剂师的工具。
Can Pharm J (Ott). 2019 Aug 13;152(5):291-300. doi: 10.1177/1715163519866232. eCollection 2019 Sep-Oct.
2
Combination antiplatelet therapy: implications for pharmacists.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6):880-3. doi: 10.1331/108658002762063745.
3
[Retrospective analysis of correlative factors between digestive system injury and anticoagulant or antiplatelet-agents].消化系统损伤与抗凝或抗血小板药物相关性因素的回顾性分析
Zhonghua Yi Xue Za Zhi. 2014 May 27;94(20):1553-8.
4
Bleeding following rattlesnake envenomation in patients with preenvenomation use of antiplatelet or anticoagulant medications.在使用抗血小板或抗凝药物进行预先蛇毒处理的患者中，响尾蛇咬伤后的出血情况。
Acad Emerg Med. 2014 Mar;21(3):301-7. doi: 10.1111/acem.12333.
5
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.巨细胞动脉炎患者的抗血小板和抗凝治疗。
Arthritis Rheum. 2006 Oct;54(10):3306-9. doi: 10.1002/art.22141.
6
Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users.抗凝和/或抗血小板使用者胃肠道出血后的再出血、血管事件和死亡风险。
Aliment Pharmacol Ther. 2019 Oct;50(8):919-929. doi: 10.1111/apt.15441. Epub 2019 Sep 4.
7
Interaction between Traditional Chinese Medicine and Anticoagulant/Antiplatelet Drugs.中药与抗凝/抗血小板药物的相互作用。
Curr Drug Metab. 2019;20(9):701-713. doi: 10.2174/1389200220666190827160212.
8
Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis.抗血小板/抗凝治疗对巨细胞动脉炎患者严重缺血性并发症的影响：累积荟萃分析。
Autoimmun Rev. 2014 Aug;13(8):788-94. doi: 10.1016/j.autrev.2014.02.006. Epub 2014 Mar 22.
9
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.冠状动脉支架置入术后抗血小板治疗与抗凝治疗的随机对照比较。
N Engl J Med. 1996 Apr 25;334(17):1084-9. doi: 10.1056/NEJM199604253341702.
10
Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients.老年患者复杂抗血栓治疗的下消化道和上消化道出血、输血和住院风险。
Circulation. 2013 Oct 22;128(17):1869-77. doi: 10.1161/CIRCULATIONAHA.113.004747. Epub 2013 Sep 11.
本文引用的文献
1
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.心房颤动急性冠状动脉综合征或经皮冠状动脉介入治疗后的抗血栓治疗。
N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.
2
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.2018 年加拿大心血管学会/加拿大介入心脏病学会抗血小板治疗应用指南重点更新
Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19.
3
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.房颤患者 PCI 术后的达比加群双重抗血栓治疗。
N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.
4
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.利伐沙班联合或不联合阿司匹林用于稳定型心血管疾病。
N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.
5
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.经皮冠状动脉介入治疗（PCI）的房颤患者的出血预防。
N Engl J Med. 2016 Dec 22;375(25):2423-2434. doi: 10.1056/NEJMoa1611594. Epub 2016 Nov 14.
6
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.《加拿大心血管学会心房颤动管理指南2014年重点更新》
Can J Cardiol. 2014 Oct;30(10):1114-30. doi: 10.1016/j.cjca.2014.08.001. Epub 2014 Aug 13.
7
Rivaroxaban in patients with a recent acute coronary syndrome.利伐沙班用于近期急性冠状动脉综合征患者。
N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.
8
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
9
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.
10
Apixaban with antiplatelet therapy after acute coronary syndrome.急性冠脉综合征后应用阿哌沙班联合抗血小板治疗。
N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.
Zotero 插件